EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitSystematische ÜbersichtOpen Access

Safety and efficacy of pemigatinib in patients with cholangiocarcinoma: a systematic review

Warda Rasool, Yassine Alami Idrissi iD, Owais Ahmad, Shree Rath, Fatima Saeed, Mohamed Saad Sayed, Bhavya Sharma, Arwa Amer Ibrahim, Ajanta Kumari, Irfan Ullah, Anwaar Saeed

Journal of Gastrointestinal Oncology · 2025-04 · 16 (2) · 699-710

DOI: 10.21037/jgo-2024-923 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Gastrointestinal Oncology, 2025-04. Verfasst von Warda Rasool und 10 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, King Edward Medical University, Lahore, Pakistan. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Cholangiocarcinoma (CCA)FGFR inhibitorspemigatinibtargeted therapy

Autor:innen und Institutionen

  • Faculty of Medicine, King Edward Medical University, Lahore, Pakistan.
  • University of Pittsburgh Medical Center (UPMC) & UPMC Hillman Cancer Center, Pittsburgh, PA, USA.
  • Islamic International Medical College, Riphah International University, Rawalpindi, Pakistan.
  • All India Institute of Medical Sciences, Bhubaneswar, India.
  • United Medical and Dental College, Karachi, Pakistan.
  • Faculty of Medicine, Beni-Suef University, Beni Suef, Egypt.

ORCID-Profile: Yassine Alami Idrissi

Zitieren

APA

Rasool, W., Alami Idrissi, Y., Ahmad, O., Rath, S., Saeed, F., Sayed, M. S., Sharma, B., Ibrahim, A. A., Kumari, A., Ullah, I., & Saeed, A. (2025). Safety and efficacy of pemigatinib in patients with cholangiocarcinoma: a systematic review. Journal of Gastrointestinal Oncology, 16(2), 699-710. https://doi.org/10.21037/jgo-2024-923

Vancouver

Rasool W, Alami Idrissi Y, Ahmad O, Rath S, Saeed F, Sayed MS, et al. Safety and efficacy of pemigatinib in patients with cholangiocarcinoma: a systematic review. Journal of Gastrointestinal Oncology. 2025;16(2):699-710. doi:10.21037/jgo-2024-923

BibTeX
@article{Rasool2025,
  author = {Rasool, Warda and Alami Idrissi, Yassine and Ahmad, Owais and Rath, Shree and Saeed, Fatima and Sayed, Mohamed Saad and Sharma, Bhavya and Ibrahim, Arwa Amer and Kumari, Ajanta and Ullah, Irfan and Saeed, Anwaar},
  title = {Safety and efficacy of pemigatinib in patients with cholangiocarcinoma: a systematic review},
  journal = {Journal of Gastrointestinal Oncology},
  year = {2025},
  volume = {16},
  number = {2},
  pages = {699--710},
  doi = {10.21037/jgo-2024-923}
}
Kostenlos starten →